0001140361-23-050238.txt : 20231030 0001140361-23-050238.hdr.sgml : 20231030 20231030165352 ACCESSION NUMBER: 0001140361-23-050238 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231018 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAYNE RICHARD A CENTRAL INDEX KEY: 0000884413 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 231361030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 3 1 form3.xml X0206 3 2023-10-18 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0000884413 KAYNE RICHARD A 1900 AVENUE OF THE STARS, #1000 LOS ANGELES CA 90067 true Common Stock 1667100 I See footnote. Common Stock 2700000 I See footnote. Common Stock 729886 I See footnote. Mr. Kayne shares control of Propel Bio Partners LLC, a Delaware limited liability company ("Propel General Partner"). Mr. Kayne and Propel General Partner act as the general partner of, or otherwise provide discretionary advisory services to, one or more private investment funds, and such investment funds directly own 1,667,100 shares of Common Stock. Mr. Kayne provides discretionary advisory services to an investment company registered under the Investment Company Act of 1940, as amended, and such investment company directly owns 2,700,000 shares of Common Stock. Mr. Kayne is the trustee and beneficiary of the Richard Kayne and Suzanne Kayne Living Trust dtd 01/14/1999, a California trust (the "Family Trust"), and The Family Trust directly owns 729,886 shares of Common Stock. Mr. Kayne expressly disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any pecuniary interest. /s/ Richard A. Kayne 2023-10-30